Company Quick10K Filing
EVIO
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2018-12-31 Quarter: 2018-12-31
10-K 2018-09-30 Annual: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-Q 2017-12-31 Quarter: 2017-12-31
10-K 2017-09-30 Annual: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-Q 2016-12-31 Quarter: 2016-12-31
10-K 2016-09-30 Annual: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-Q 2015-12-31 Quarter: 2015-12-31
10-K 2015-09-30 Annual: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-Q 2014-12-31 Quarter: 2014-12-31
8-K 2019-11-20 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-08-27 Sale of Shares
8-K 2019-06-20 Other Events
8-K 2019-05-20 Enter Agreement, Leave Agreement, Regulation FD
8-K 2019-05-01 Enter Agreement, Exhibits
8-K 2019-03-20 Other Events
8-K 2019-02-13 Accountant, Exhibits
8-K 2019-01-17 M&A, Regulation FD, Other Events
8-K 2018-12-31 Officers
8-K 2018-11-19 Officers
8-K 2018-10-15 Regulation FD
8-K 2018-08-27 M&A, Sale of Shares, Exhibits
8-K 2018-08-15 Officers
8-K 2018-06-27 Enter Agreement, M&A, Off-BS Arrangement, Exhibits
8-K 2018-06-22 Officers, Exhibits
8-K 2018-05-02 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-04-29 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-04-18 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-04-16 Enter Agreement, Officers, Exhibits
8-K 2018-02-06 Enter Agreement
8-K 2018-01-30 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-01-01 Enter Agreement, M&A, Off-BS Arrangement, Exhibits
8-K 2017-12-27 Sale of Shares, Exhibits

EVIO Financials

-

EVIO Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Ryanair Holdings (RYAA) 13,250,700 8,035,800 0 0 0 0 -34,900
Lingo Media (LMDC) 1,302 743 0 0 0 0 -0
China Crawfish (CACA) 2 0 0 0 -4 -4 -3
Apollo Education (APOL) 1,063,295 1,955,243 886,324 2,000,328 0 -19,719 98,213 579,272
Granite Real Estate (GRP)
Weyland Tech (WEYL) 10,602 5,280 29,462 -958 -4,242 -4,099 -5,303
Mirenco (MREO)
Baynon (BNON) 11 145 0 0 -21 -20 99
Green Planet Bio Engineering (GPLB) 3,001 0 272 0 0 -38 -38 3,001
G-Mes Holdings (GMES) 1,262 812 652 609 67 141 -31
Immune Therapeutics (IMUN) 0 24 12,553 0 34 -5,080 -5,079 -21
Therapeutic Solutions (TSOI) 0 367 1,851 13 10 -1,579 -1,236 481
Blue Sphere (BLSP) 894 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Frontier Digital Media Group (FDMG) 5 31 32 0 -29 -29 -3
Stem Holdings (STEMH) 40,803 5,703 958 364 -8,070 -7,496 -5,454
MWF Global (MWF) 0 0 -34 -34 -1
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 27 16,749 0 0 -5,795 -3,052 894
Brighthouse Life Insurance Co of Ny (BHNY) 9,065,749 8,029,864 236,819 0 0 2,514 -190,199
Imine (JRVS) 5,585 2 590 0 0 -1,527 -1,527 6,083

Balance Sheet ($'000)2014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-31
Cash316426123146571522651501212223,02182210
Accounts Receivable51051278119242228146230203216414252
Inventory
PP&E22951591671703077617671,9625,2495,988
Assets681161447297087212,1722,1863,8793,9963,9716,0186,16711,30814,35517,613
Accounts Payable4443114672104136246
Long-Term Debt
Liabilities74831144434437222,0222,5932,9493,4303,1335,7925,2568,09310,41215,060
Stockholders' Equity-63330285265-2150-4079295668382259113,2143,9432,552
Income Statement ($'000)2014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-31
Revenue566108171105117169668833777743947902-1,4611,187
Cost of Revenue0005906146545987368801,304
Gross Profit5667821912314421122-117
R&D
SG&A30775321279262223242584354615829768202,4511,497
Tax00000000000002
Net Income-25-775-320-336-70-340-421-1,721-821-465-570-1,734-994-1,685-2,651
Cash Flow ($'000)2014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-31
Cash Operating-32-36-43-83-2-62-96-117-8-367-159-192-1,956-248
Cash Investing-2-4-1013-9-29-27-33-19-3-1,002-7-784-555
Cash Financing38524291-3841021841352551,1323005,540934